Company news
Bolt Biotherapeutics, Inc. news in 2022
Bolt Biotherapeutics, Inc.'s news releases, calls and decks from 2022, newest first.
Bolt Biotherapeutics Appoints Laura Berner to Board of Directors
December 13, 2022
Bolt Biotherapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
November 9, 2022
Bolt Biotherapeutics to Present Preclinical Data on BDC-3042, Dectin-2 Targeting Agonistic Antibody, at the SITC Annual Meeting
November 6, 2022
Bolt Biotherapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
August 9, 2022
Bolt Biotherapeutics Reports First Quarter 2022 Financial Results and Provides Business Highlights
May 11, 2022
Bolt Biotherapeutics Reports Four Quarter and Full Year 2021 Financial Results and Provides Business Highlights
March 29, 2022
Bolt Biotherapeutics Doses First Patient with BDC-1001 in Combination with OPDIVO® (nivolumab) in Ongoing Phase 1/2 Clinical Trial for the Treatment of HER2-Expressing Solid Tumors
January 5, 2022